Article Information
History
- September 26, 2023.
Article Versions
- You are currently viewing Version 1 of this article (September 26, 2023 - 19:07).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marcos Chiñas1,3,
- Daniela Fernandez-Salinas1,3,4,
- Vitor R. C. Aguiar1,2,3,
- Victor E. Nieto-Caballero1,3,4,
- Micah Lefton5,
- Peter A. Nigrovic1,2,5,
- Joerg Ermann2,5,* and
- Maria Gutierrez-Arcelus1,2,3,*
- 1Division of Immunology, Boston Children’s Hospital, Boston, MA, USA
- 2Harvard Medical School, Boston, MA, USA
- 3Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA
- 4Licenciatura en Ciencias Genomicas, Centro de Ciencias Genomicas, Universidad Nacional Autónoma de México (UNAM), Morelos 62210, Mexico
- 5Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital, Boston, MA 02115, USA
- ↵*Co-corresponding authors: Maria Gutierrez-Arcelus, Boston Children’s Hospital, Division of Immunology, Karp Family Research Laboratories, Room 102016.1, 1 Blackfan Circle, Boston, MA, 02115, mgutierr{at}broadinstitute.org, 857-559-3229, Joerg Ermann, Brigham and Women’s Hospital, Division of Rheumatology, Inflammation and Immunity, Hale Building for Transformative Medicine, Room 6002P, 60 Fenwood Road, Boston, MA, 02115, jermann{at}bwh.harvard.edu, 617-525-1227
Posted September 26, 2023.
Functional genomics implicates natural killer cells as potential key drivers in the pathogenesis of ankylosing spondylitis
